SPH3643: A novel cyclin-dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood-brain barrier permeability.
Liao X, Hong Y, Mao Y, Chen N, Wang Q, Wang Z, Zhang L, Wang L, Shi C, Shi W, Ge H, Li A, Li X, Xia G, Liu Y.
Liao X, et al. Among authors: li x, li a.
Cancer Sci. 2020 May;111(5):1761-1773. doi: 10.1111/cas.14367. Epub 2020 Mar 24.
Cancer Sci. 2020.
PMID: 32103527
Free PMC article.